Thinking. Ahead. In Neurotechnology.
We are providing tomorrows solutions in neurotechnology already today.
We are creating new ways of communication between electrical signals of the body and modern information technology.
Our technology enables our partners and customers to develop new therapies.
Who we are.
CorTec is a young medtech company that was founded in Freiburg, Germany, in September 2010. In summer of 2018 CorTec moved into new premises closeby the Airport Campus of the University of Freiburg with own clean room facilities.
As leading experts for innovations in the field of medical engineering we are following the vision to take implantable neurotechnologies to the next level.
Our complete system, the CorTec Brain Interchange Platform, as well as its components, such as electrodes or hermetic packaging. realize the communication with the central and peripheral nervous system.
We are offering the most relevant components for the development of innovative personalized therapies for different neural diseases.
What we stand for.
We provide solutions for the communication with the nervous system – to enable our customers to develop novel and effective therapies and medical devices.
Our active implant technologies pave the way for new perspectives on the treatment of neurological disorders. The overall goal is to improve the life quality of people suffering from neurological diseases.
Learn more about possible applications for our products.
We aim to become the leading technology partner for the development of neurotherapies. We are already working on the next generation of active implantable technologies that will revolutionize the market for medical devices, especially for active implants.
Great ideas require a strong team that is working closely together. Learn more about our team, our management and our advisory boards.
We have to meet the highest standards in everything that we do. Learn more about our Quality Management System and our certifications.
In cooperation with our investors we work on the future success of our developments and on our further corporate growth.